Suchergebnisse - "Moningka, Remond"

PubPharm (8)

1

A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells

enthalten in: ACS chemical biology | 2022

von Moore, K. | Schwaid, A. | Tudor, M. | +36

2

Fragment-based lead discovery of a novel class of small molecule antagonists of neuropeptide B/W receptor subtype 1 (GPR7)

enthalten in: Bioorganic & medicinal chemistry letters | 2020

von Moningka, R. | Romero, F. | Hastings, N. | +10

3

Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists

enthalten in: ACS medicinal chemistry letters | 2018

von Liu, W. | Hussain, Z. | Zang, Y. | +14

4

SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS

enthalten in: Europäisches Patentamt | 2018

von DUFFY JOSEPH L | BAO JIANMING | ONDEYKA DEBRA L | +10

5

The discovery of potent antagonists of NPBWR1 (GPR7)

enthalten in: Bioorganic & medicinal chemistry letters | 2012

von Anthony Romero, F. | Hastings, N. | Moningka, R. | +10

6

The discovery of potent antagonists of NPBWR1 (GPR7)

enthalten in: Bioorganic & medicinal chemistry letters | 2012

von Anthony Romero, F. | Hastings, N. | Moningka, R. | +10

7

A one-pot three-component reaction to access 1-alkyl-2-aryl-5-nitrobenzimidazoles under solvent-free conditions

enthalten in: Tetrahedron letters | 2010

von Romero, F. | Moningka, R.

8

Formal total synthesis of ((plus-minus))-martinellic acid

enthalten in: Tetrahedron letters | 2005

von He, Y. | Moningka, R. | Lovely, C.

1
[1]